Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Serial electrophysiological studies in a Guillain-Barré subtype with bilateral facial neuropathy.
G protein-coupled receptor kinase 2 moderates recruitment of THP-1 cells to the endothelium by limiting histamine-invoked Weibel-Palade body exocytosis.
Bisphenol-A Impairs Myelination Potential During Development in the Hippocampus of the Rat Brain.
The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?
Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits.
Elevated CSF histamine levels in multiple sclerosis patients.
Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease.
Annexin A1 and the regulation of innate and adaptive immunity.
A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination.
The patients with clinically isolated syndrome and relapsing remitting multiple sclerosis show different levels of advanced protein oxidation products and total thiol content in sera and csf.
Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME.
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Fatigue in multiple sclerosis is not due to sleep apnoea.
Multiple Autoimmune-Associated Variants Confer Decreased IL-2R Signaling in CD4(+)CD25(hi) T Cells of Type 1 Diabetic and Multiple Sclerosis Patients.
Variants of MicroRNA Genes: Gender-Specific Associations with Multiple Sclerosis Risk and Severity.
A Young Woman With Blurred Vision and Distal Paresthesias.
Improved Lesion Detection by Using Axial T2-Weighted MRI with Full Spinal Cord Coverage in Multiple Sclerosis.
Microglia Transcriptome Changes in a Model of Depressive Behavior after Immune Challenge.
Molecular mechanisms of scar-sourced axon growth inhibitors.
Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's disease: morphometric study and review of the literature.
GABA: a new imaging biomarker of neurodegeneration in multiple sclerosis?
High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis.
The Role of Geranylgeranyltransferase I-Mediated Protein Prenylation in the Brain.
Systematic review of clinical practice guidelines related to multiple sclerosis.
Neuroinflammation: Modulating mighty microglia.
Pages
« first
‹ previous
…
605
606
607
608
609
610
611
612
613
…
next ›
last »